98 related articles for article (PubMed ID: 11064897)
21. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
22. Benign prostatic hyperplasia: treat or wait?
Davidson JH; Chutka DS
J Fam Pract; 2008 Jul; 57(7):454-63. PubMed ID: 18625168
[TBL] [Abstract][Full Text] [Related]
23. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
O'Leary MP; Wei JT; Roehrborn CG; Miner M;
BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
[TBL] [Abstract][Full Text] [Related]
24. Effects of serum PSA on efficacy of tolterodine extended release with or without tamsulosin in men with LUTS, including OAB.
Roehrborn CG; Kaplan SA; Kraus SR; Wang JT; Bavendam T; Guan Z
Urology; 2008 Nov; 72(5):1061-7; discussion 1067. PubMed ID: 18817961
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of IPSS and ICS male SF in the initial assessment of urinary disorders].
Perrin P; Némoz C; Paparel P; Ruffion A
Prog Urol; 2008 Sep; 18(8):519-26. PubMed ID: 18760742
[TBL] [Abstract][Full Text] [Related]
26. Natural history of voiding function after radical retropubic prostatectomy.
Namiki S; Ishidoya S; Saito S; Satoh M; Tochigi T; Ioritani N; Yoshimura K; Terai A; Arai Y
Urology; 2006 Jul; 68(1):142-7. PubMed ID: 16777193
[TBL] [Abstract][Full Text] [Related]
27. International Prostate Symptom Scores in young asymptomatic American men.
Mueller ER; Latini J; Lux M; Kreder K; Fitzgerald MP
BJU Int; 2005 Mar; 95(4):554-6. PubMed ID: 15705079
[TBL] [Abstract][Full Text] [Related]
28. A cross-sectional study of the international prostate symptom scores related to age and gender in Dutch adults reporting no voiding complaints.
van Haarst EP; Heldeweg EA; Newling DW; Schlatmann TJ
Eur Urol; 2005 Mar; 47(3):334-9. PubMed ID: 15716197
[TBL] [Abstract][Full Text] [Related]
29. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.
Dib PT; Trigo-Rocha F; Gomes CM; Srougi M
Urol Int; 2008; 80(4):378-82. PubMed ID: 18587248
[TBL] [Abstract][Full Text] [Related]
30. The need for voiding diaries in the evaluation of men with nocturia.
Jaffe JS; Ginsberg PC; Silverberg DM; Harkaway RC
J Am Osteopath Assoc; 2002 May; 102(5):261-5. PubMed ID: 12033755
[TBL] [Abstract][Full Text] [Related]
31. Patient-reported outcome after carpal tunnel release for advanced disease: a prospective and longitudinal assessment in patients older than age 70.
Leit ME; Weiser RW; Tomaino MM
J Hand Surg Am; 2004 May; 29(3):379-83. PubMed ID: 15140475
[TBL] [Abstract][Full Text] [Related]
32. Significant relationship of time-dependent uroflowmetric parameters to lower urinary tract symptoms as measured by the International Prostate Symptom Score.
Itoh H; Kojima M; Okihara K; Ukimura O; Ushijima S; Kawauchi A; Miki T
Int J Urol; 2006 Aug; 13(8):1058-65. PubMed ID: 16903930
[TBL] [Abstract][Full Text] [Related]
33. Mode of administration of international prostate symptom score in patients with lower urinary tract symptoms: physician vs self.
Cam K; Akman Y; Cicekci B; Senel F; Erol A
Prostate Cancer Prostatic Dis; 2004; 7(1):41-4. PubMed ID: 14999237
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of storage and voiding symptoms among men aged 40 years and older in a US population-based study: results from the Male Attitudes Regarding Sexual Health study.
Glasser DB; Carson C; Kang JH; Laumann EO
Int J Clin Pract; 2007 Aug; 61(8):1294-300. PubMed ID: 17627708
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of lower urinary tract symptoms and bother in both sexes.
Terai A; Matsui Y; Ichioka K; Ohara H; Terada N; Yoshimura K
Urology; 2004 Mar; 63(3):487-91. PubMed ID: 15028443
[TBL] [Abstract][Full Text] [Related]
36. Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms.
Namiki S; Saito S; Ishidoya S; Tochigi T; Ioritani N; Yoshimura K; Terai A; Arai Y
Urology; 2005 Jul; 66(1):147-51. PubMed ID: 15992905
[TBL] [Abstract][Full Text] [Related]
37. Lower urinary tract symptoms in 1,912 apparently healthy persons of both sexes.
Shimabukuro T; Takahashi Y; Naito K
Hinyokika Kiyo; 2006 Mar; 52(3):189-95. PubMed ID: 16617872
[TBL] [Abstract][Full Text] [Related]
38. Effect of dutasteride, tamsulosin and the combination on patient-reported quality of life and treatment satisfaction in men with moderate-to-severe benign prostatic hyperplasia: 2-year data from the CombAT trial.
Barkin J; Roehrborn CG; Siami P; Haillot O; Morrill B; Black L; Montorsi F;
BJU Int; 2009 Apr; 103(7):919-26. PubMed ID: 19239460
[TBL] [Abstract][Full Text] [Related]
39. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
40. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
